Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,024 | 57,536 | 56,357 | 193,650 | 95,036 |
| Marketable Securities | 168,086 | 123,322 | 148,145 | N/A | 99,254 |
| Receivables | 2,419 | 1,903 | 1,090 | 35,986 | 1,712 |
| TOTAL | $201,204 | $187,801 | $212,277 | $237,102 | $200,280 |
| Non-Current Assets | |||||
| PPE Net | 4,060 | 4,499 | 4,573 | 5,072 | 5,710 |
| Intangibles | 1,715 | 1,751 | 1,788 | 1,824 | 1,860 |
| Other Non-Current Assets | 14,188 | 15,134 | 15,992 | 16,893 | 18,642 |
| TOTAL | $19,963 | $21,384 | $22,353 | $23,789 | $26,212 |
| Total Assets | $221,167 | $209,185 | $234,630 | $260,891 | $226,492 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 4,082 | N/A |
| Accounts payable and accrued liabilities | 1,705 | 1,029 | 2,203 | 2,809 | 5,176 |
| Accrued Expenses | 20,689 | 20,068 | 22,275 | 24,450 | 31,340 |
| TOTAL | $146,790 | $141,377 | $151,262 | $152,608 | $97,841 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 124,396 | 120,280 | 126,784 | 121,267 | 61,325 |
| Other Non-Current Liabilities | 13,354 | 11,962 | 12,872 | 13,975 | 15,055 |
| TOTAL | $125,615 | $152,835 | $170,005 | $194,034 | $100,177 |
| Total Liabilities | $272,405 | $294,212 | $321,267 | $346,642 | $198,018 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 66,989 | 66,768 | 66,339 | 66,228 | 66,084 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -724,285 | -727,277 | -726,190 | -722,879 | -605,089 |
| Other shareholders' equity | -63 | 35 | 26 | 10 | -795 |
| TOTAL | $-51,238 | $-85,027 | $-86,637 | $-85,751 | $28,474 |
| Total Liabilities And Equity | $221,167 | $209,185 | $234,630 | $260,891 | $226,492 |